Keywords: pharmaceutical, sales, continue, drive, growth, akzo, nobel
Pharmaceutical sales continue to drive growth at Akzo Nobel
Article | 25 October 2000
Akzo Nobel of the Netherlands says that net income for the third quarterof 2000 soared 25% to 242 million euros ($202.2 million) or 0.85 euros ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
